U.S. MARKETS FOR INTERVENTIONAL CARDIOLOGY PRODUCTS

270 Pages | 68 Exhibits | 2014 Analysis | Forecasts Through 2018

OVERVIEW:
Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from coronary heart disease (CHD), which is the single largest cause of death in the U.S. and also is the greatest cause of premature and permanent disability in the labor force; CHD is responsible for more than 50% of all cardiovascular events in men and women younger than age 75, and for 1 out of every 6 deaths.

Interventional cardiology is a continually evolving area of medicine that involves the use of catheter-based, or transcatheter, tools and techniques to diagnose and treat coronary vascular and structural disorders. Today, interventional techniques, which came into widespread use in the mid-1980s, are a mainstay for the diagnosis and treatment of patients with CHD. In 2013, diagnostic and therapeutic interventional cardiology methods were employed in approximately 5.5 million procedures in the U.S., generating approximately $3.8 billion in corresponding products sales; it is expected that, in the year 2018, these methods will be employed in nearly 5.7 million procedures in the U.S., generating an estimated $4.3 billion in corresponding product sales.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional cardiology devices to the U.S.

Covered topics in this report include atherectomy, cardiovascular disease statistics, coronary angiography, coronary stenting, drug-eluting balloon angioplasty, guidewire-based physiologic intravascular stenosis assessment, intracardiac echocardiography, intravascular ultrasound, percutaneous transluminal coronary angioplasty, thrombectomy, transcatheter septal defect repair, and vascular access site closure, among others.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY
 
i. Diagnostic Interventional Cardiology Products 
	a. Coronary Angiography Systems 
	b. Guidewire-Based Physiologic Intravascular Stenosis Assessment Products 
	c. Intracardiac Echocardiography Products 
	d. Intravascular Ultrasound Products 
ii. Therapeutic Interventional Cardiology Products 
	a. Percutaneous Transluminal Coronary Angiography Devices 
	b. Coronary Stent Systems 
	c. Atherectomy Systems 
	d. Thrombectomy Systems 
	e. Transcatheter Septal Defect Repair Devices 
	f. Vascular Access Site Closure Devices 
iii. Methodology 

Exhibit ES-1: Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018 
Exhibit ES-2: Interventional Cardiology Products, Combined Market Forecast, 2013-2018 
Exhibit ES-3: Diagnostic Interventional Cardiology Systems Market Share, by Product Segment, 2013 and 2018 
Exhibit ES-4: Therapeutic Interventional Systems Market Share,  by Product Segment, 2013 and 2018 

1. HEART DISEASE OVERVIEW
 
1.1 The Heart and Circulatory System 
1.2 Selected Heart Diseases/Disorders 
	1.2.1 Coronary Heart Disease 
		1.2.1.1 Atherosclerosis 
		1.2.1.2 Angina Pectoris 
		1.2.1.3 Myocardial Infarction 
	1.2.2 Hypertension 
		1.2.2.1 Systolic and Diastolic Pressures 
		1.2.2.2 Prehypertension 
	1.2.3 Cardiomyopathy 
		1.2.3.1 Dilated Cardiomyopathy 
		1.2.3.2 Hypertrophic Cardiomyopathy 
		1.2.3.3 Restrictive Cardiomyopathy 
	1.2.4 Congenital Heart Defects 
		1.2.4.1 Ventricular Septal Defects 
		1.2.4.2 Atrial Septal Defects 
		1.2.4.3 Patent Ductus Arteriosus 
	1.2.5 Heart Failure 
		1.2.5.1 Disease Development 
		1.2.5.2 Ejection Fraction Reduction 
		1.2.5.3 Classification/Staging Systems 

Exhibit 1-1: Cross-Section Diagram of the Heart 
Exhibit 1-2: Statistics for Selected Coronary Heart Disease Risk Factors 
Exhibit 1-3: Standard Angina Pectoris Classification 
Exhibit 1-4: Angina Pectoris, Selected Statistics 
Exhibit 1-5: Clinical Classification of AMI 
Exhibit 1-6: Myocardial Infarction, Selected Statistics 
Exhibit 1-7: Percentage of Adults Who Have Been Told They Have High Blood Pressure, by State 
Exhibit 1-8: Hypertension, Selected Statistics 
Exhibit 1-9: Cardiomyopathy, Selected Statistics 
Exhibit 1-10: Congenital Heart Defects, Selected Statistics 
Exhibit 1-11: Summary, New York Heart Association Heart Failure Classification System 
Exhibit 1-12: Summary, American College of Cardiology/American Heart Association Heart Failure Staging System 
Exhibit 1-13: Heart Failure, Selected Statistics 

2. DIAGNOSTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS
 
2.1 Coronary Angiography 
	2.1.1 Technologies 
	2.1.2 Procedure Volumes
	2.1.3 Products 
	2.1.4 Market Forecast 
	2.1.5 Competitors 
2.2 Guidewire-Based Physiologic Intravascular Stenosis Assessment 
	2.2.1 Technologies 
	2.2.2 Procedure Volumes 
	2.2.3 Products 
	2.2.4 Market Forecast 
	2.2.5 Competitors 
2.3 Intracardiac Echocardiography 
	2.3.1 Technologies 
	2.3.2 Procedure Volumes 
	2.3.3 Products 
	2.3.4 Market Forecast 
	2.3.5 Competitors 
2.4 Intravascular Ultrasound 
	2.4.1 Technologies 
	2.4.2 Procedure Volumes 
	2.4.3 Products 
	2.4.4 Market Forecast 
	2.4.5 Competitors 

Exhibit 2-1: Diagnostic Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018 2-3
Exhibit 2-2: Diagnostic Interventional Cardiology Products, Combined Market Forecast, 2013-2018 
Exhibit 2-3: Coronary Angiography, Procedure Volumes Forecast, 2013-2018 
Exhibit 2-4: 2014, Selected Angiography Catheters 
Exhibit 2-5: 2014, Selected Diagnostic Guidewires 
Exhibit 2-6: 2014, Selected Introducers/Sheaths 
Exhibit 2-7: Coronary Angiography Devices, Market Forecast, 2013-2018 
Exhibit 2-8: 2013, Coronary Angiography Devices Market, Share by Supplier 
Exhibit 2-9: Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes Forecast, 2013-2018 
Exhibit 2-10: 2014, Selected Consoles and Guidewires for Physiologic Intravascular Stenosis Assessment 
Exhibit 2-11: Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2013-2018 
Exhibit 2-12: 2013, Physiologic Intravascular Stenosis Assessment Guidewire Systems Market, Share by Supplier 
Exhibit 2-13: Intracardiac Echocardiography, Procedure Volumes Forecast, 2013-2018 
Exhibit 2-14: 2014, Selected Intracardiac Echocardiography Catheters 
Exhibit 2-15: Intracardiac Echocardiography Catheters,  Market Forecast, 2013-2018 
Exhibit 2-16: 2013, Intracardiac Echocardiography Catheters Market,  Share by Supplier 
Exhibit 2-17: Intravascular Ultrasound, Procedure Volumes Forecast, 2013-2018 
Exhibit 2-18: 2014, Selected Intravascular Ultrasound Products 
Exhibit 2-19: Intravascular Ultrasound Products, Market Forecast, 2013-2018 
Exhibit 2-20: 2013, Intravascular Ultrasound Products Market,  Share by Supplier 

3. THERAPEUTIC INTERVENTIONAL CARDIOLOGY PROCEDURES AND PRODUCTS 

3.1 Percutaneous Transluminal Coronary Angioplasty 
	3.1.1 Technologies 
		3.1.1.1 Approaches 
		3.1.1.2 Complications/Efficacy 
	3.1.2 Procedure Volumes Forecast 
	3.1.3 Products 
		3.1.3.1 Balloon Catheters 
		3.1.3.2 Guiding Catheters 
		3.1.3.3 Guidewires 
		3.1.3.4 Introducers/Sheaths 
		3.1.3.5 Accessories 
	3.1.4 Market Forecast 
	3.1.5 Competitors 
3.2 Coronary Stenting 
	3.2.1 Technologies 
		3.2.1.1 Stent Materials, Coatings/Surfaces, and Anti-Restenosis Agents 
		3.2.1.2 Stent Deployment 
		3.2.1.3 Indications 
		3.2.1.4 Complications/Efficacy 
	3.2.2 Procedure Volumes Forecast 
	3.2.3 Products 
	3.2.4 Market Forecast 
	3.2.5 Competitors 
3.3 Coronary Atherectomy 
	3.3.1 Technologies 
	3.3.2 Procedure Volumes Forecast 
	3.3.3 Products 
	3.3.4 Market Forecast 
	3.3.5 Competitors 
3.4 Coronary Thrombectomy 
	3.4.1 Technologies 
	3.4.2 Procedures Volumes Forecast 
	3.4.3 Products 
	3.4.4 Market Forecast 
	3.4.5 Competitors 
3.5 Transcatheter Septal Defect Repair 
	3.5.1 Technologies 
		3.5.1.1 Atrial Septal Defect Repair 
		3.5.1.2 Patent Ductus Arteriosus Repair 
		3.5.1.3 Ventricular Septal Defect Repair 
	3.5.2 Procedure Volumes Forecast 
	3.5.3 Products 
	3.5.4 Market Forecast 
	3.5.5 Competitors 
3.6 Vascular Access Site Closure Devices 
	3.6.1 Technologies 
	3.6.2 Procedure Volumes Forecast 
	3.6.3 Products 
	3.6.4 Market Forecast 
	3.6.5 Competitors 

Exhibit 3-1: Therapeutic Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018 
Exhibit 3-2: Therapeutic Interventional Cardiology Products, Combined Market Forecast, 2013-2018 
Exhibit 3-3: Percutaneous Transluminal Coronary Angioplasty, Procedure Volumes Forecast, 2013-2018 
Exhibit 3-4: 2014, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters 
Exhibit 3-5: 2014, Selected Guiding Catheters for Coronary Interventions 
Exhibit 3-6: 2014, Selected Guidewires for Coronary Interventions 
Exhibit 3-7: 2014, Selected Introducers/Sheaths for Coronary Interventions 
Exhibit 3-8: 2014, Selected Inflation Devices for Coronary Interventions 
Exhibit 3-9: Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2013-2018 
Exhibit 3-10: 2013, Percutaneous Transluminal Coronary Angioplasty Devices Market, Share by Supplier 
Exhibit 3-11: 2014, Selected Anti-Restenosis Agents 
Exhibit 3-12: Coronary Stenting, Procedure Volumes Forecast, 2013-2018 
Exhibit 3-13: 2014, Selected Coronary Stent Systems/Stents 
Exhibit 3-14: Coronary Stent Systems, Market Forecast, 2013-2018 
Exhibit 3-15: 2013, Coronary Stent Systems Market, Share by Supplier 
Exhibit 3-16: Coronary Atherectomy, Procedure Volumes Forecast,  2013-2018 
Exhibit 3-17: 2014, Selected Coronary Atherectomy Systems 
Exhibit 3-18: Coronary Atherectomy Systems, Market Forecast, 2013-2018 
Exhibit 3-19: 2013, Coronary Atherectomy Systems Market, Share by Supplier 
Exhibit 3-20: Coronary Thrombectomy, Procedure Volumes Forecast, 2013-2018 
Exhibit 3-21: 2014, Selected Coronary Thrombectomy Systems Exhibit 3-22: Coronary Thrombectomy Systems, Market Forecast, 2013-2018 
Exhibit 3-23: 2013, Coronary Thrombectomy Systems Market,  Share by Supplier 
Exhibit 3-24: Transcatheter Septal Defect Repair, Procedure Volumes Forecast, 2013-2018 
Exhibit 3-25: 2014, Selected Transcatheter Septal Defect Repair Devices 
Exhibit 3-26: Transcatheter Septal Defect Repair Devices,  Market Forecast, 2013-2018 
Exhibit 3-27: 2013, Transcatheter Septal Defect Repair Devices Market,  Share by Supplier 
Exhibit 3-28: Vascular Access Site Closure, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-29: 2014, Selected Vascular Access Site Closure Devices 
Exhibit 3-30: Vascular Access Site Closure Devices,  Market Forecast, 2013-2018 
Exhibit 3-31: 2013, Vascular Access Site Closure Devices Market, Share by Supplier 

APPENDIX:  COMPANY LISTING 



COMPANIES COVERED:

  1. Aachen Resonance GmbH
  2. Abbott Laboratories
  3. Abbott Vascular/Abbott Laboratories
  4. AccessClosure, Inc.
  5. Alvimedica
  6. AngioScore
  7. Angiotech Pharmaceuticals, Inc.
  8. Arrow International, Inc./Teleflex, Inc.
  9. ASAHI Intecc Company LTD
  10. Atrium Medical Corporation/Maquet Holding/Getinge Group
  11. B. Braun Melsungen AG
  12. Bayer AG
  13. Bayer HealthCare AG/Bayer AG
  14. Bayer Schering Pharma AG/Bayer AG
  15. Biosense Webster/Johnson & Johnson
  16. Biosensors International
  17. BIOTRONIK SE & Co, KG
  18. Blue Medical Devices BV/Welliq
  19. Boston Scientific Corporation
  20. Cardia, Inc.
  21. Cardiovascular Systems, Inc.
  22. Cardiva Medical, Inc.
  23. CeloNova Biosciences, Inc.
  24. Control Medical Technology LLC
  25. Cook Medical/Cook Group, Inc.
  26. Cordis Corporation/Johnson & Johnson
  27. CordynaMIC/Iberhospitex SA
  28. Covidien
  29. DISA Vascular PTY LTD
  30. Edwards Lifesciences Corporation
  31. Elixir Medical Corporation
  32. eucatech AG
  33. Eurocor GmbH/Opto Circuits India LTD
  34. General Electric Healthcare/General Electric Company
  35. HemCon Medical Technologies, Inc.
  36. Hexacath
  37. InSitu Technologies, Inc.
  38. Johnson & Johnson
  39. Kaneka Medical Products/Kaneka Medix Corporation
  40. Kyoto Medical Planning Corporation LTD
  41. Maquet Holding/Getinge Group
  42. Marine Polymer Technologies, Inc.
  43. Maxcor/Opto Circuits India LTD
  44. MEDRAD Interventional Possis/Bayer HealthCare AG/Bayer AG
  45. Medtronic, Inc.
  46. Merit Medical Systems, Inc.
  47. Micell Technologies, Inc.
  48. MicroPort Scientific Corporation
  49. Minvasys
  50. Novartis Pharmaceutical Corporation/Novartis AG
  51. OrbusNeich
  52. REVA Medical, Inc.
  53. Sahajanand Medical
  54. Scion BioMedical, Inc.
  55. Siemens AG
  56. Siemens Healthcare/Siemens AG
  57. Spectranetics Corporation
  58. St. Jude Medical, Inc.
  59. Terumo Interventional Systems/Terumo Corporation
  60. Translumina GmbH
  61. Vascular Concepts/Vascular Concepts Group
  62. Vascular Solutions, Inc.
  63. Volcano Corporation
  64. W.L. Gore & Associates, Inc.
Contact Us

Need help finding medtech research? Let us help you!